These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

360 related items for PubMed ID: 19217673

  • 1. Statin therapy in the elderly: a review.
    Szadkowska I, Stanczyk A, Aronow WS, Kowalski J, Pawlicki L, Ahmed A, Banach M.
    Arch Gerontol Geriatr; 2010; 50(1):114-8. PubMed ID: 19217673
    [Abstract] [Full Text] [Related]

  • 2. [Statins in older patients: limits to prescription?].
    Bosshard Taroni W, Büla C, Darioli R.
    Rev Med Suisse; 2005 Nov 02; 1(39):2512-4, 2516-7. PubMed ID: 16323731
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The statin studies: from targeting hypercholesterolaemia to targeting the high-risk patient.
    Ong HT.
    QJM; 2005 Aug 02; 98(8):599-614. PubMed ID: 16006501
    [Abstract] [Full Text] [Related]

  • 5. Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men.
    Bennett S, Sager P, Lipka L, Melani L, Suresh R, Veltri E, Ezetimibe Study Group.
    J Womens Health (Larchmt); 2004 Dec 02; 13(10):1101-7. PubMed ID: 15650343
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Statins for stroke prevention: disappointment and hope.
    Amarenco P, Tonkin AM.
    Circulation; 2004 Jun 15; 109(23 Suppl 1):III44-9. PubMed ID: 15198966
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [HMG-CoA reductase inhibitors in prevention of cardiovascular diseases: new mechanisms, aspects and trials].
    Wojakowski W, Gmiński J.
    Przegl Lek; 2000 Jun 15; 57(5):291-5. PubMed ID: 11057120
    [Abstract] [Full Text] [Related]

  • 12. Frequency of statin use in type 2 diabetics having macrovascular disease- at a Tertiary Care Hospital of Karachi.
    Basit A, Hydrie MZ, Hakeem R, Ahmedani MY, Masood Q.
    J Ayub Med Coll Abbottabad; 2004 Jun 15; 16(4):60-4. PubMed ID: 15762067
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Does aggressive statin therapy offer improved cholesterol-independent benefits compared to conventional statin treatment?
    Gupta S.
    Int J Cardiol; 2004 Aug 15; 96(2):131-9. PubMed ID: 15262025
    [Abstract] [Full Text] [Related]

  • 17. Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention?
    Mora S, Ridker PM.
    Am J Cardiol; 2006 Jan 16; 97(2A):33A-41A. PubMed ID: 16442935
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.
    Cheng AY, Leiter LA.
    Curr Opin Cardiol; 2006 Jul 16; 21(4):400-4. PubMed ID: 16755211
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.